cprx stock price target

Catalyst Pharmaceuticals Incs number of analysts covering the stock is. The companys non-GAAP EPS rose 636 from its prior-year quarter to 018.

Ideas And Forecasts On Catalyst Pharmaceuticals Inc Nasdaq Cprx Tradingview

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1200 and a low estimate of 875.

. Analysts consensus targets ratings and recommendations Nasdaq. Get the latest Catalyst Pharmaceutical Partners stock price and detailed information including CPRX news historical charts and realtime prices. The average twelve-month price target for Catalyst Pharmaceuticals is 1092 with a high price target of 1200 and a low price target of 875.

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1200 and a low estimate of 875. Catalyst Pharmaceuticals Stock Forecast CPRX stock price prediction. Catalyst Pharmaceutical CPRX closed the last trading session at 741 gaining 229 over the past four weeks but there could be plenty of.

Its operating income grew 678 from its year-ago value to 1737 million while its non-GAAP net income amounted to 1940 million up 679 from its prior-year quarter. The average price target is 1092 with a high forecast of 1200 and a low forecast of 875. On average they expect Catalyst Pharmaceuticals stock price to reach 1092 in the next year.

The average price target is 000 with a high estimate of 000 and a low estimate of 000. Based on 3 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. CPRX stock quote history news and other vital information to help you with your stock trading and investing.

Find the latest Catalyst Pharmaceuticals Inc. This suggests a possible upside of 589 from the stocks current price. 5 Wall Street analysts that have issued a 1 year CPRX price target the average CPRX price target is 1160 with the highest CPRX stock price forecast at 1500 and the lowest CPRX stock price forecast at 900.

Analyst ratings historical stock prices earnings estimates actuals. The consensus price target hints at a 333 upside potential for Catalyst CPRX. CPRX analyst stock forecast price target and recommendation trends with in.

On the other hand Catalyst Pharms target price is what analysts think the stock is worth or could sell for in the future. Find the latest Catalyst Pharmaceuticals Inc. The best long-term short-term Catalyst Pharmaceuticals.

According to the issued ratings of 4 analysts in the last year the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average price target represents a 6697 change from the last price of 654. Analyst Price Target on CPRX.

In the first quarter ending March 31 2022 CPRXs total revenue increased 427 year-over-year to 4309 million. CPRXs average price target has moved up 265 over the prior 29 weeks. Get a real-time Catalyst Pharmaceuticals Inc.

Price target in 14 days. Get a real-time Catalyst Pharmaceuticals Inc. Over the past 50 weeks CPRXs average upside potential has been 466.

For Catalyst Pharmaceuticals stock forecast for 2022 8 predictions are offered for each month of 2022 with average Catalyst Pharmaceuticals stock forecast of 814 a high forecast of 83 and a low forecast of 795. During the day the stock fluctuated 482 from a day low at 717 to a day high of 751. CPRX stock price news historical charts analyst ratings and financial information from WSJ.

The average Catalyst Pharmaceuticals stock forecast 2022 represents a 117 increase from the last price of 805000019073486. While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Based on analysts offering 12 month price targets for CPRX in the last 3 months.

Analyst estimates including CPRX earnings per share estimates and analyst recommendations. The more significant the discrepancy. Catalyst Pharms current and average target prices are 706 and 980 respectively.

View the latest Catalyst Pharmaceuticals Inc. The current price of Catalyst Pharm is the price at which Catalyst Pharm is currently trading. CPRX stock forecast and price target.

1117 388 Earnings Date. CPRX stock price quote with breaking news financials statistics charts and more. The Trend in the Analyst Price Target.

CPRX updated stock price target summary. 4 analysts have issued 1 year target prices for Catalyst Pharmaceuticals stock. Close price at the end of the last trading day Friday 6th May 2022 of the CPRX stock was 722.

This is 412 less than the trading day before Thursday 5th May 2022. CPRX stock price quote with breaking news financials statistics charts and more. Their forecasts range from 875 to 1200.

The median estimate represents a 6644 increase from the last price of 721.

Catalyst Cprx Up More Than 20 In Past 3 Months Here S Why